Herron, J. W. and Mitchell, A. (2018) Depression and antidepressant prescribing in the elderly. Prescriber, 29(3), pp. 12-17. (doi: 10.1002/psb.1654)

Wilson, M. R. , Docherty, K. F. and Gardner, R. S. (2016) Use of direct oral anticoagulants in thromboembolic disease. Prescriber, 27(8), pp. 15-22. (doi: 10.1002/psb.1487)

Williams, C. and Mcclay, C.-A. (2015) What are the options for managing phobias? Prescriber, 26(9), pp. 25-28. (doi: 10.1002/psb.1348)

Chaplin, S. and Krishnadas, R. (2014) Properties and use of SSRIs for depressive disorders. Prescriber, 25(22), pp. 14-26. (doi: 10.1002/psb.1283)

Martin, D. and Smith, D. (2013) Bipolar disorder - diagnosis and current treatment options. Prescriber, 24(11), pp. 36-39. (doi: 10.1002/psb.1071)

McHugh, B. and Krishnadas, R. (2011) Guide to safely withdrawing antidepressants in primary care. Prescriber, 22(17), pp. 36-40. (doi: 10.1002/psb.793)

Lang, N. and Fox, K. (2010) Current drug therapies used in the secondary prevention of MI. Prescriber, 21(19), pp. 22-45. (doi: 10.1002/psb.675)

McKay, G. (2009) Drug development: have we seen the end of the blockbuster? Prescriber, 20(4), pp. 48-50.

Lang, N. and Fox, K. (2008) Current drug therapies for the secondary prevention of MI. Prescriber, 19(1), pp. 14-25. (doi: 10.1002/psb.173)

Lang, N. and Fox, K. (2005) Current drug therapies for the secondary prevention of MI. Prescriber, 16(12), pp. 33-44.

Lowe, G. (2005) Diagnosis and management of intermittent claudication. Prescriber, 2005, pp. 36-44.

Basu, N. and Reid, D.M. (2005) Paget’s disease of the bone. Prescriber, 16(21), pp. 37-41.

Smith, D.J. and Livingston, M.G. (2005) Quality and Outcomes Framework standards: monitoring lithium. Prescriber, 16(5), pp. 32-35.